Lung Adenocarcinoma with Paraneoplastic Hyper-Eosinophilia Not Responding To Pembrolizumab.
Hisham WehbeMaria KozahSalwa A KoubaissiPublished in: Clinical medicine insights. Circulatory, respiratory and pulmonary medicine (2021)
Pre-treatment hyper-eosinophilia could represent a predictive factor of an unfavorable response to ICI treatment in cases of NSCLC. Additional similar cases are needed to draw a more conclusive relationship.